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Abstract
Background: African swine fever (ASF) is a re-expanding devastating viral disease currently threatening the pig
industry worldwide. MicroRNAs are a class of 17–25 nucleotide non- coding RNAs that have been shown to have critical
functions in a wide variety of biological processes, such as cell differentiation, cell cycle regulation, carcinogenesis,
apoptosis, regulation of immunity as well as in viral infections by cleavage or translational repression of mRNAs.
Nevertheless, there is no information about miRNA expression in an ASFV infection.
Methods: In this proof-of-concept study, we have analyzed miRNAs expressed in spleen and submandibular lymph node
of experimentally infected pigs with a virulent (E75) or its derived attenuated (E75CV1) ASFV strain, as well as, at different
times post-infection with the virulent strain, by high throughput sequencing of small RNA libraries.
Results: Spleen presented a more differential expression pattern than lymph nodes in an ASFV infection. Of the most
abundant miRNAs, 12 were differentially expressed in both tissues at two different times in infected animals with the
virulent strain. Of these, miR-451, miR-145-5p, miR-181a and miR-122 presented up-regulation at late times post-infection
while miR-92a, miR-23a, miR-92b-3p, miR-126-5p, miR-126-3p, miR-30d, miR-23b and miR-92c showed down-regulation.
Of the 8 differentially expressed miRNAs identified at the same time post-infection in infected animals with the virulent
strain compared with animals infected with its attenuated strain, miR-126-5p, miR-92c, miR-92a, miR-30e-5p and miR-
500a-5p presented up-regulation whereas miR-125b, miR-451 and miR-125a were down-regulated. All these miRNAs have
been shown to be associated with cellular genes involved in pathways related to the immune response, virus-host
interactions as well as with several viral genes.
Conclusion: The study of miRNA expression will contribute to a better understanding of African swine fever virus
pathogenesis, essential in the development of any disease control strategy.
Background
African swine fever (ASF) is an infectious disease affect-
ing domestic and wild pigs caused by African swine fever
virus (ASFV) belonging to the Asfarviridae family. ASFV
is an icosahedral, enveloped, dsDNA virus ranging from
170 to 193 kb [1]. ASF genomes contain between 150
and 175 ORFs with 34 of them encoding for structural
viral proteins and so far, half of them do not have any
known function [2]. Sixteen different genomes have been
fully sequenced corresponding to virulent, attenuated
and non-pathogenic ASFV strains isolated from pigs,
wild boars, ticks and tissue culture cells. So far, 22 geno-
types have been identified with several of them currently
co-circulating in Sub-Saharan Africa. ASF was first de-
scribed in 1921 in Kenya [3] spreading rapidly through-
out other African countries. The disease is endemic in
most of Sub-Saharan Africa and in Sardinia [4]. ASFV
entered Europe for the first time in the early fifties
remaining on the continent until its eradication from
Spain and Portugal in 1995 [5]. In 2007 the virus re-
entered Europe through Georgia and since then it has
spread to East-Europe, becoming a real threat for all
Europe. Confirming the menace, in 2014 four countries
from the EU declared ASF outbreaks [6]. From 2014 to
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date, the presence of the disease and more outbreaks
have been reported by the World Organization for
Animal Health (OIE) in Estonia, Latvia, Lithuania, Poland,
Russia, Belarus, Moldova and Ukraine while recently
(June 2017), Czech Republic has reported its first case
of ASFV [7].
ASFV transmission is produced by direct contact be-
tween infected and susceptible animals and alternatively,
following indirect transmission routes through contami-
nated pork, fomites, vehicles, people and ticks. The disease
is characterized by an acute form that leads to fever, hem-
orrhages and several lesions causing death in a short period
of time. High mortality leads to huge economical losses in
affected areas [7, 8]. Experimental infections occur with
the development of clinical signs at 7–10 days post inocu-
lation that can be considered late times of infection. At
that time, histopathological evaluation shows typical alter-
ations of the disease such as macrophage infiltrations and
apoptotic cells together with a cytokine storm characteris-
tic of the terminal phase in ASF infections according to
previous studies [9].
No commercial vaccine is available in spite of the
efforts carried out to achieve it. Engineered live attenu-
ated strains and cell culture adapted virus have been the
two most common approaches used to obtain a candi-
date vaccine [10, 11]. Cell culture adaptation leads to
attenuation that generally ends rendering non-pathogenic
viruses invalid for vaccine purposes. The genomic changes
responsible of the phenotypic modification and the mech-
anisms involved are not well understood [12].
MicroRNAs (miRNAs) are small RNA molecules that
can regulate gene expression post-transcriptionally. miR-
NAs derive from the primary miRNA (pri-miRNA) [13],
which is transcribed in the nucleus and processed into a
precursor (pre-miRNAs) by the endonuclease Drosha
and DCGR8 [14]. The pre-miRNA molecule is trans-
ported to the cytoplasm by exportin-5 [15, 16]. Another
endonuclease, Dicer [17], processes the pre-miRNA to
generate the double-stranded 18–23 nt miRNA duplex.
The mature miRNA strand in which the first 2–8 nucle-
otides (seed region) are essential for recognizing the
target mRNA, is incorporated into the RNA-induced
silencing complex [18, 19] in order to regulate gene
expression by decreasing mRNA stability and/or block
translation [20].
miRNAs have an enormous capacity of regulation and
have been shown to play key regulatory roles in many bio-
logical processes like development, differentiation, homeo-
stasis, carcinogenesis, apoptosis, regulation of immunity
as well as in viral infections [21]. miRNAs have been
identified in many species, from mammals to metazoans,
funguses, plants and viruses. Studies on differential ex-
pression patterns of miRNAs have been carried out after
virus infections, most of them in cell culture meanwhile a
few of them have been performed in the natural host. In
this proof-of-concept study, miRNA expression has been
analyzed by using high throughput sequencing (HTS) in
two tissues, spleen and submandibular lymph node (SLN),
recovered at early times post-infection from pigs infected
with two ASFV strains of different virulence and, on the
other hand, the miRNA expression in these two tissues at
different times post-infection in animals inoculated with
the virulent strain E75 have been compared. The changes
found in miRNA expression due to the virus infection
could lead to a better understanding of the virus-host
interactions and provide useful information to find new
targets in order to control the infection. The information
provided from this proof-of-concept study reinforces the
application of this approach for future analysis using a
higher number of animals and conditions.
Methods
Animals
Tissue samples analyzed in this study were derived from
an experimental ASFV infection included in the investiga-
tion of ASFV pathogenesis and vaccine development [10].
Two different viruses were used. First, the España- 75
(E75) virulent strain (accession number FN557520), a very
infectious and virulent strain causing almost a 100%
mortality classified within p72 genotype I. This virus was
isolate in an outbreak in Lerida in 1975 [1, 22]. And sec-
ondly, the E75CV1, an attenuated strain derived from the
E75 strain obtained by cellular passage in a stable line of
monkey kidney fibroblasts, the kidney of an adult male
African green monkey (Cercopithecus aethiops) [23].
From the in vivo infection, available samples of four 8-
week-old Landrace x Large White pigs were used. Sub-
mandibular lymph node (SLN) and spleen samples from
two pigs intramuscularly inoculated with 104 HAU of
the E75 virulent strain [10] and SLN and spleen samples
from two pigs inoculated with same amount (104 HAU) of
the E75CV1, were used. One animal inoculated with the
virulent strain and two with the attenuated strain were
necropsied at 3 days post-infection (dpi). At 7 dpi, one
animal inoculated with the virulent strain was necropsied.
All animal experiments conducted by Lacasta et al. (2015)
were performed at CReSA facilities under biosafety level 3
(BSL-3) and all procedures were carried out in strict ac-
cordance with the guidelines of the institutional animal
ethics committee of Universitat Autònoma de Barcelona
(UAB), with the permit number DMAH-5796 for this
specific study, according to the Spanish and European ani-
mal experimentation ethics law. Animals were euthanized
following the European Directive 2010/63/EU, using an
anaesthetic overdose of 60–100 mg of pentobarbital per
kilogram of weight administered via the vena cava.
SLN and spleen samples were collected and immedi-
ately frozen at −80 °C.
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Homogenate and DNA- RNA extraction
Tissue samples of approximately 100 mg were homoge-
nized with a pestle in 1 mL of Trizol (Thermo Fisher
Scientific, Massachusetts, United States) to lyse the tissues
and deactivate virus. Total RNA and DNA were isolated
following the manufacturer’s protocol and resuspended in
25 and 200 μL of RNAse-, DNAse- and proteinase free
water (Sigma- Aldrich, St. Louis, United States) for RNA
and DNA, respectively.
Real- time PCR
ASFV qPCR on both tissues was carried out in order to
quantify viral load. SYBR Green qPCR was the selected
procedure with pF1 primer (5′ CCTCGGCGAGCGCTT
TATCAC 3′) as forward primer and pR2 (5′ GGAAACT
CATTCACCAAATCCTT 3′) as the reverse one that were
designed to target a highly conserved region within the
p72 ORF as described by [24]. The mix for the qPCR
contained 480 nM each primer, 12.5 μl Power SYBR®
Green PCR Master Mix (Thermo Fisher Scientific) and
2.5 μl template. Nanopure autoclaved water was added to
final volume of 25 μl. The conditions for the amplification
were 10 min at 95 °C, 2 min at 50 °C and 40 cycles of 15 s
at 95 °C and 1 min at 60 °C. Triplicates of each sample
were used for the qPCR.
RNA integrity and quantification
Total RNA was quantified using ND 1000 Nanodrop®
Spectrophotometer (Thermo Fisher Scientific). RNA in-
tegrity and quality was analyzed using the 2100 Expert
Bioanalizer (Agilent Technologies, Santa Clara, USA).
Total and low size RNA measurements were carried out.
Total RNA was calculated using the Eukaryote total
RNA Nano Series II software and specific chips (Agilent
Technologies, Santa Clara, USA), while low size RNA
was measured using the Small RNA Nano software and
specific chips (Agilent Technologies, Santa Clara, USA).
Small RNA library construction
All procedures were carried out using the miRCat™
microRNA Cloning Kit (IDT, Iowa, USA) protocol as
basis, with the modifications described in [25]. For the en-
richment of the small RNA fraction, slices were cut from
a 12% denaturing (7 M Urea) polyacrylamide gel, using a
miSPIKE™ (IDT, Iowa, USA), as internal size marker.
Small RNA fractions were purified using Performa DTR
gel filtration cartridges (EdgeBio, Gaithersburg, USA). A
double ligation was carried out using 3′ and 5′ linkers
from miRCatTM kit (IDT, Coralville, USA) in two steps.
The 3′ preadenylated linker was coupled to the small
RNA fraction in a reaction in which the mix contained 1X
Reaction Buffer for T4 Ligase (Thermo Fisher Scientific)
without ATP, 0.1 mg BSA (Thermo Fisher Scientific), 1 U
T4 RNA ligase (Thermo Fisher Scientific) and 2.5 μM 3′
linker. 6.5 μL small RNA fraction was added and incu-
bated at 37 °C for 2 h. The 5′ linker was coupled in a mix
with 1X ligation buffer (Thermo Fisher Scientific), 1 U T4
RNA ligase (Thermo Fisher Scientific) and 50 μM 5′
linker in presence of ATP. 7.5 μL 3′linked RNA was added
to a final volume of 10 μL. The mixture was incubated for
2 h at 37 °C.
RT- PCR
RT was carried out with Super Script III Reverse Tran-
scriptase (Thermo Fisher Scientific). Initial pre incubation
at 65 °C for 5 min with 0.5 mM of each dNTP, 0.5 μM
Primer mir5 and 11 μL RNA were carried out. In a second
step a mix was prepared with 1X First-Strand Buffer,
5 mM DTT, 0.2 U RNaseOUT and 10 U SuperScript III
RT in a final volume of 20 μL, the mix was incubated at
55 °C for 90 min, and 70 °C for 15 min.
PCR amplifications were performed using Expand
High Fidelity Plus PCR System (Roche Diagnostics, Basel,
Switzerland). Briefly, 0.05 U Expand High Fidelity Plus
Enzyme Blend, 1X Expand High Fidelity Plus Reaction
Buffer with 1.5 mM MgCl2, 0.2 μM Primers A5 and B3
(included multiplex identifiers at the 5′ end), 0.2 μM of
each dNTP, 4 μL cDNA and RNAse free water to a final
volume of 50 μL. PCR conditions were 94 °C for 3 min,
20–25 cycles at 94 °C for 30 s, 57 °C for 45 s and 72 °C for
1 min followed by 71 °C for 7 min. The number of cycles
was optimized for each library to avoid saturation. The
resulting PCR was purified with the QIAquick PCR purifi-
cation kit (Quiagen, Hilden, Germany).
Cloning in the pGEM-T Easy Vector System II Kit
(Promega Corporation, Wisconsin, United States) and
posterior Sanger sequencing with the ABI-PRISM 3700
(Thermo Fisher Scientific) were carried out to check the
libraries construction prior to the HTS.
High throughput sequencing
PCR amplifications from each library were quantified using
Qubit™ fluorometer, Quant-IT™ (Invitrogen™, Carlsbad,
USA) and prepared to a 1011 DNA molecules/μL. As they
included multiplex identifiers, they were equimolecular
pooled to continue in one reaction. Ion Torrent adapters
were ligated to 30 ng of pooled DNA and libraries were
then amplified with Ion Torrent primers for 8 cycles and
size selected (2% E-Gel Size Select, Invitrogen). Libraries
were sequenced following the manufacturer’s protocol
with Ion PGM™ sequencer (Thermo Fisher Scientific,
Massachussetts, USA) at DNA sequencing facilities at
CRAG (Bellaterra, Spain). Software version for base call-
ing was Torrent-Suite v2.0.1, (Thermo Fisher Scientific,
Massachussetts USA). Sequencing data were deposited
at European Nucleotide Archive (ENA, http://www.ebi.
ac.uk/ena/) [26] with the accession number PRJEB17083.
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Sequence processing scheme and miRNA expression
statistics
Primer sequences were trimmed and only those insert
sequences between 15 and 29 nucleotides and with total
number of sequences ≥3 were kept for further analysis.
For porcine miRNA profiling, sequences were compared
to all available miRNA sequences (miRBase v21) using
local Blast. Parameters were set to 100% identity and up
to 4 mismatches allowed at the end of the sequences to
solve the miRNA variability on 3′ and 5′ ends [27].
Differences in host miRNA expression were assessed.
The total number of sequences obtained for each porcine
miRNA was normalized by library size (in counts per
thousand) and, then, averaged by group. Fold changes
(FC) between groups were calculated using normalized
data. Only miRNAs up or down-regulated for all individ-
uals per group were taking into account. miRNAs were
considered differentially expressed (DE) with a FC > 5,
and highly expressed with a copy number > 80, according
with a previous study from our group [28].
miRNA target prediction and biological functions
For the in silico study of the potential targets, the
DIANA-microT-CDS v5.0 web server with an adjusted
threshold of 0.7 was used [29, 30]. There were no porcine
genes in the databases, so the study was done using the
human genome assuming sequence conservation [31]. In
order to identify potential targets in the viral genome,
the miRanda program was used with the following
parameters: -sc 140 –en 20. Potential targets were
then studied employing Web-based Gene Set Analysis
Toolkit (WebGestal) [32, 33]. The analysis was done using
the Kyoto Encyclopedia of Genes and Genomes Database
(KEGG) to check the biological pathways in which miR-
NAs are involved. The selected parameters for the study
were the multiple test adjustment by Benjamini and
Hochberg [34] and the significance level set at 0.05.
Finally, Cytoscape 3.2.1 software [35] was used in order
to build the gene regulatory networks formed by the DE
miRNAs and their cellular and viral target genes.
Results
Animal infection
Pigs inoculated with the E75CV1 attenuated strain de-
veloped no clinical signs while pigs inoculated with the
E75 virulent strain developed typical African swine fever
clinical signs [10]. Samples from three animals necropsied
at 3 dpi as early times of infection and from one pig inoc-
ulated with the virulent strain euthanized at 7 dpi because
of the development of severe clinical signs were analyzed.
These time points reflect early times of infection (3dpi)
where low viral load and mild clinical/ histopathological
signs were observed, and, on the other hand late times of
infection (7 dpi) where very high viral load was detected
with severe and lethal clinical and histopathological signs.
At 3 dpi animals presented no fever but a reduction of
their activity and mild awkwardness in their movement
with few hemorrhages or cyanotic areas and low dyspnea.
Histopathology showed mild bleeding, splenic infarcts,
hyperplasia, necrosis, lymphocytolysis or vascular damage
in spleen. At 7 dpi animals presented high fever with mild
movement or even immobile, high percentage of cyanotic
areas, cutaneous necrosis and hemorrhages, bloody faeces
and dyspnea. Histopathology showed bleeding, lymphoid
depletion, splenic infarcts, necrosis and massive hemor-
rhages in spleen). Ct values in tissue samples determined
by qPCR are indicated in Table 1. DNA from attenuated
virus was not detected at 3 dpi by qPCR. Animals in-
cluded in the study of Lacasta et al. (2015), inoculated
with the attenuated strain and maintained until 31 dpi
showing neither viremia nor clinical signs of acute ASF
except fever episodes at 7 dpi that reached undetectable
levels by 28 dpi.
miRNA sequence annotation
RNAs from SLN and spleen were used to prepare small
RNA libraries from animals euthanized at 3 and 7 dpi. A
total of 8 small RNA libraries from both tissues were con-
structed and sequenced with an Ion Torrent PGM sequen-
cer. From the 301,802 total reads obtained, after trimming
the adaptor sequences, the number of inserts comprising
15 to 29 nt were 105,156. Sequences were aligned to miR-
Base database (v.21) and a total of 66,599 hits were ob-
tained, corresponding to 366 entries in miRBase.
Analysis of the miRNA expression in animals infected with
the virulent ASFV strain at different times post-infection
The normalized count of sequencing reads (reads/total
sequencing tags in the library) could be used to quantify
miRNA expression levels among early (3 dpi) and late (7
dpi) in both analyzed tissues. miRNAs were considered
differentially expressed (DE) with a FC > 5, and highly
expressed with a copy number > 80, according with a
previous study from our group [28].
From the 14 miRNAs expressed at higher levels (>80
reads) in spleen, 9 miRNAs (64.3%) were DE, two were
up-regulated at 7 dpi when compared with 3 dpi (miR-451
and miR-145-5p) and 6 down-regulated (Table 2). Inter-
estingly, miR-451 and miR-145-5p were the most repre-
sented miRNAs among all miRNAs, with more than two
Table 1 Ct values from ASFV inoculated pigs
Animal number
Tissue 1 2 3 4
SLN 31.99 27.81 – –
Spleen 27.71 24.6 – –
Animals 1 and 2 were inoculated with the E75 virulent strain, animals 3 and 4
were inoculated with the E75CV1 attenuated strain
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and one thousand counts found at day 7 for E75-infected
pigs, respectively. Among the down regulated miRNAs,
miR-126-5p presented the highest FC differences with 225
FC. In SLN, from the 25 miRNAs more expressed (>80),
six miRNAs (24%) were DE, two up-regulated at 7 dpi
when compared with 3 dpi (miR-181a and miR-145-5p)
and four down-regulated (Table 3). As has been shown in
spleen, miR-126-5p was the miRNA with the highest FC
(41.84) in SLN. A more conserved miRNA expression pat-
tern was observed in SLN than in spleen.
Analysis of miRNA expression in attenuated and virulent
ASFV strains infected animals at early times post- infection
The normalized count of sequencing reads (reads/total
sequencing tags in the library) could be used to quantify
miRNA expression levels among virulent and attenuated
ASFV infected pigs at early times post-infection (3 dpi).
miRNAs were considered DE with a FC > 5 and when
the up- or down-regulation was conserved for both ani-
mals infected with the E75CV1 strain.
From the 22 more expressed miRNAs (>80 reads) in
spleen, 7 miRNAs (31.8%) were DE, four up-regulated in
virulent ASFV infected animal (miR-92a, miR-126-5p,
miR-92c and miR-30e-5p) and 3 down-regulated (miR-
125b, miR-451 and miR-125a) (Table 4). In SLN, from the
33 more expressed miRNAs (>80), three miRNAs (9.1%)
were DE, two up-regulated in virulent infected animal
(miR-30e-5p and miR-500a-5p) and one down-regulated
(miR-125a) (Table 5). miR-303-5p and miR-125a presented
the same regulation in both tissues analyzed, up and down
regulated, respectively. In this case, the miRNA expression
seems also to be more conserved in SLN than in spleen at
that time post-infection.
Interestingly, only two miRNAs were equally regulated
in spleen and SLN when comparing tissues from virulent
and attenuated ASFV infected animals at 3 dpi. Thus,
while the ssc-miR-125a showed a down-regulation in its
expression, ssc-miR-30e-5p was overexpressed in tissues
infected with virulent ASFV when compared to animals
infected with the attenuated strain.
miRNA target prediction and biological pathways analysis
Target predictions were carried out for DE miRNAs. Ten
miRNAs were selected for target prediction according to
the highest representation by tissue and conditions: miR-
23a, miR-30e-5p, miR-92a, miR-122, miR-125b, miR-126-
5p, miR-145-5p, miR-125a, miR-451 and miR-126-3p.
From these ten miRNAs a total of 8774 target genes
were identified (Additional file 1). Cellular target genes
Table 2 Differences in the expression of miRNAs in spleen
between virulent ASFV infected animals
miRNA 7 dpi/3 dpi Reads
bta-miR-451 46.15 2305
ssc-miR-145-5p 12.39 1212
ssc-miR-92a −21.02 445
ssc-miR-23a −7.92 285
ssc-miR-92b-3p −13.79 271
hsa-miR-25-3p −2.10 203
ssc-miR-126-5p −224.86 202
ssc-miR-23b −16.74 152
ssc-miR-26a −1.61 151
ssc-miR-122 106/0 106
ssc-miR-125b −3.29 96
ssc-miR-21 1.83 92
ssc-miR-181a 1.06 88
bfl-miR-92c −13.87 86
The most represented miRNAs (CN >80) are indicated. miRNAs were
considered DE when FC was higher than 5 between 7 dpi and 3 dpi samples
of infected pigs
Table 3 Differences in the expression of miRNAs in SLN
between virulent ASVF infected animals
miRNA 7dpi/3 dpi Reads
ssc-miR-126-3p −9.32 1892
ssc-miR-23a −2.49 1576
ssc-miR-126-5p −41.84 622
ssc-miR-23b −5.14 586
ssc-miR-26a −1.06 530
ssc-miR-125b 1.54 447
ssc-miR-92a −1.05 440
ssc-miR-21 4.69 431
hsa-let-7b-5p 2.67 423
hsa-miR-25-3p −1.05 412
ssc-miR-92b-3p 2.30 312
ssc-miR-15b 1.32 284
ssc-miR-150 1.29 257
ssc-miR-99a −1.54 199
ssc-miR-10b −2.07 180
ssc-miR-30e-5p −2.80 174
ssc-miR-30d −7.11 161
ssc-miR-100 −1.29 137
ssc-miR-181a 5.36 131
ssc-miR-16 4.20 116
ssc-miR-99b −2.97 115
ssc-miR-378 −2.92 113
bfl-miR-92c 1.00 109
ssc-miR-145-5p 5.87 95
hsa-miR-500a-5p −4.09 94
The most represented miRNAs (CN >80) are indicated. miRNAs were
considered DE when FC was higher than 5 between 7 dpi and 3 dpi in
samples of infected pigs
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were functionally analyzed through the KEGG pathways
database (Table 6). For 7 miRNAs: miR-23a, miR-30e-
5p, miR-92a, miR-122, miR-125b, miR-126-5p and miR-
125a, significant pathways were found related to immune
response such as B and T cell receptor signaling pathway,
natural killer cell mediated cytotoxicity or Fc gamma R-
mediated phagocytosis and with some processes related to
the pathogenesis and virus-host interaction, like desencap-
sidation, apoptosis inhibition, autophagy or host DNA
damage response. For miR-451, miR-126-3p and miR-
145-5p, no pathways were identified, although some of the
target genes have been related to ASFV infection.
Gene regulatory network
DE miRNAs were analyzed with the miRanda algorithm
in order to identify the possible targets in the ASFV gen-
ome. For miRNA expression in animals infected with
the virulent ASFV at different dpi, a total of 25 interac-
tions were found for the seven DE miRNAs and the an-
notated 165 genes in ASFV genome (Fig. 1). Also, 42
interactions were identified with the porcine genes
involved in virus-host interactions such as: apoptosis,
chemokine receptors, endoplasmic reticulum (ER) stress,
transcription factors, autophagy, ATM pathway, virus
entry, immune response and replication. For miRNA ex-
pression in attenuated and virulent infected animals at
early times post-infection, 16 interactions were found for
the five DE miRNAs and the annotated genes in ASFV
genome (Fig. 2) and 45 interactions were identified with
the porcine genes involved in virus-host interaction, like:
chemokine receptors, ER stress, apoptosis, transcription
factors, autophagy, virus entry and P300 coactivator pro-
tein. In a global approach, considering all DE miRNAs
Table 4 Differences in the expression of spleen miRNAs
between virulent and attenuated ASFV infected animals
miRNA Virulent/ Attenuated Reads
ssc-miR-125b −6.64 1496
ssc-miR-23a −1.42 1266
ssc-miR-23b −1.31 642
ssc-miR-92a 13.06 508
ssc-miR-92b-3p 3.29 478
bta-miR-451 −5.80 446
ssc-miR-125a −7.59 440
ssc-miR-145-5p −2.63 418
ssc-miR-126-5p 12.42 250
hsa-miR-25-3p 3.14 213
ssc-miR-99a −2.05 211
ssc-miR-378 −2.14 194
hsa-let-7b-5p 1.06 172
ssc-miR-126-3p 2.03 162
ssc-miR-100 −3.03 145
ssc-miR-30d 2.04 130
ssc-miR-26a 2.86 129
ssc-miR-99b −1.85 127
ssc-miR-21 −1.59 93
bfl-miR-92c 13.58 90
ssc-miR-30e-5p 5.70 90
ssc-miR-150 −1.02 84
The most represented miRNAs (CN >80) are indicated. DE miRNA were
considered as those suffering >5 FC
Table 5 Differences in the expression of SLN miRNAs between
virulent and attenuated ASFV infected animals
miRNA Virulent/ Attenuated Reads
ssc-miR-126-3p 1.55 2601
ssc-miR-23a 1.17 2424
ssc-miR-125b −2.55 1030
ssc-miR-92b-3p −4.41 869
ssc-miR-23b 1.39 853
ssc-miR-126-5p 1.89 847
ssc-miR-92a −1.10 646
ssc-miR-26a 2.49 614
hsa-let-7b-5p −1.21 568
hsa-miR-25-3p 1.68 509
ssc-miR-21 1.03 452
ssc-miR-150 1.06 355
ssc-miR-15b 1.66 333
ssc-miR-99a −1.34 332
ssc-miR-125a −6.91 291
ssc-miR-10b 1.17 261
ssc-miR-100 −1.42 238
ssc-miR-30d 1.79 223
ssc-miR-30e-5p 6.83 183
ssc-miR-99b 1.02 182
ssc-miR-191 −2.32 164
bfl-miR-92c 1.19 145
ssc-miR-145-5p −2.48 140
ssc-miR-378 2.51 133
ssc-miR-181a 1.05 131
ssc-miR-16 1.16 115
ssc-miR-204 1.09 115
ssc-miR-218 1.28 103
hsa-miR-500a-5p 5.74 101
hsa-miR-29c-5p −1.09 96
ssc-miR-374a-5p 2.09 89
ssc-miR-186 2.57 84
efu-miR-126 −1.34 82
The most represented miRNAs (CN >80) are indicated. DE miRNA were
considered as those suffering >5 FC
Núñez-Hernández et al. Virology Journal  (2017) 14:198 Page 6 of 13
by ASFV infection condition, 37 interactions were
found between 12 DE miRNAs included and the an-
notated 165 genes in ASFV genome (Fig. 3). Also, 76
interactions were identified with the porcine genes in-
volved in virus-host interaction as previously de-
scribed for both conditions.
Table 6 Genome pathways predicted for selected miRNAs from
Kyoto Encyclopedia of Genes and Genomes
miRNA Pathways
miR-23a Endocytosis
Regulation of actin cytoskeleton
RIG-I-like receptor signaling pathway
Leukocyte transendothelial migration
Fc gamma R-mediated phagocytosis
Protein processing in endoplasmic reticulum
NOD-like receptor signaling pathway
Cell adhesion molecules (CAMs)
Chemokine signaling pathway
Apoptosis
T cell receptor signaling pathway
Hematopoietic cell lineage
Phagosome
Fc epsilon RI signaling pathway
miR-30e-5p Regulation of actin cytoskeleton
Natural killer cell mediated cytotoxicity
T cell receptor signaling pathway
B cell receptor signaling pathway
Focal adhesion
Protein processing in endoplasmic reticulum
Endocytosis
Fc epsilon RI signaling pathway
Apoptosis
Regulation of autophagy
Fc gamma R-mediated phagocytosis
Leukocyte transendothelial migration
Cell adhesion molecules (CAMs)a
Chemokine signaling pathway
mTOR signaling pathwaya
Toll-like receptor signaling pathway
RIG-I-like receptor signaling pathway
miR-92a Focal adhesion
Regulation of actin cytoskeleton
Endocytosis
Fc gamma R-mediated phagocytosis
Cell adhesion molecules (CAMs)a
Leukocyte transendothelial migration
Chemokine signaling pathway
B cell receptor signaling pathway
T cell receptor signaling pathway
miR-122 Antigen processing and presentation
Endocytosis
T cell receptor signaling pathway
Table 6 Genome pathways predicted for selected miRNAs from
Kyoto Encyclopedia of Genes and Genomes (Continued)
miRNA Pathways
miR-125b Toll-like receptor signaling pathway
Endocytosis
Apoptosis
Chemokine signaling pathway
Regulation of actin cytoskeleton
Fc epsilon RI signaling pathway
NOD-like receptor signaling pathway
Cell adhesion molecules (CAMs)a
T cell receptor signaling pathway
Natural killer cell mediated cytotoxicity
Hematopoietic cell lineage
miR-126-5p Focal adhesion
Regulation of actin cytoskeleton
T cell receptor signaling pathway
Protein processing in endoplasmic reticulum
Natural killer cell mediated cytotoxicity
B cell receptor signaling pathway
Fc epsilon RI signaling pathway
Chemokine signaling pathway
Apoptosis
Endocytosis
Regulation of autophagy
miR-145-5p Regulation of autophagy
Protein processing in endoplasmic reticulum
miR-125a Toll-like receptor signaling pathway
Endocytosis
Apoptosis
Chemokine signaling pathway
Antigen processing and presentation
Regulation of actin cytoskeleton
Fc epsilon RI signaling pathway
NOD-like receptor signaling pathway
Hematopoietic cell lineage
miR-451 –
miR-126-3p –
All target genes reflected in this table are related to the immune system and
ASFV pathogenesis. aSignal transduction
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Discussion
This study has been carried out in order to decipher the
presence and the potential role of the miRNAs during in
vivo ASFV infections and virus pathogenesis. The
miRNA DE pattern has been studied for many viruses
affecting pigs, like TGEV, PPV, Porcine cytomegalovirus,
ADV, PCV2 and PRRSV [25, 36–40], principally by using
cell culture. Only a few studies have been carried out
analyzing the expression pattern in the natural host. This
in vivo expression pattern analysis could be considered a
more reliable method to replicate the natural conditions
in which infection and host-pathogen interactions take
place [25, 28, 41]. This proof-of-concept study has
allowed the analysis of differences in miRNA expression
at different times post-infection with a virulent strain
and the expression pattern induced by virulent and at-
tenuated strains at an early time post-infection. How-
ever, further functional analysis is needed to support and
confirm these predictions. On the other hand, the use of
a high number of animals could provide a more robust re-
sults. Nevertheless, we consider that the selected samples
are representative of each group, taking into account that
the well characterized virological, clinical and immuno-
logical parameters of each group were similar [10].
As previously described [10], animals inoculated with
virulent strain E75 developed clinical signs compatible
with acute ASF detectable from 4 dpi and reaching its
peak at 7 dpi, while animals inoculated with the attenu-
ated strain E75CV1 developed no clinical signs and no
viral genome was detected at any time post-infection in
the selected tissues.
When comparing different times post-infection with the
E75-virulent strain, more than half of the spleen miRNAs
expressed at higher levels (highest copy number), were DE
(64.3%), when considering as DE those miRNAs with a
FC > 5. Interestingly, two were up-regulated at 7 dpi
(miR-451 and miR-145-5p), while the rest were down-reg-
ulated. In SLN, a minor proportion (24%) of the miR-
NAs were DE. This matches with the differential
transcription and protein profile observed in gastrohepati-
cal lymph node at these two times post-infection [10].
Regarding the differential expression pattern between
the virulent E75 and the attenuated E75CV1 at early
times post-infection (3 dpi), again, a higher differential
expression has been detected in spleen while a more
conserved pattern was observed in SLN. In spleen,
31.8% (7 out of 22) of the most represented miRNAs
(CN > 80) were DE. In SLN, the percentage decreased to
Fig. 1 Network of DE miRNA interactions in animals infected with the virulent strain at different time points. ASFV genes and porcine genes involved
in virus- host interactions are represented. Hexagon size is proportional to the miRNAs number of interactions. Circles indicate cellular genes and ovals
indicate viral genes. Colors indicate the main/s pathway/s in which they are involved or the described function of the viral genes
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9.1% (3 out of 33). Although both spleen and lymph
nodes are targets for virus replication, the different
vascularization, anatomical organization and function
might explain this differential regulation.
In SLN, the four DE miRNAs most represented at
different times after the infection with the ASFV viru-
lent strain, ssc-miR-126-3p, ssc-miR-126-5p, ssc-miR-
23b and ssc-miR-30d were down-regulated at 7 dpi,
coinciding with the massive detection of cytokines
and other immune mediators, with a marked leuco-
penia, hemorrhages and with the death of the infected
animals [10]. The cytokine storm classically described
during the acute phase of ASF might be explained at
least partially by the marked down-regulation of these spe-
cific miRNAs, previously described as key regulators of
genes involved in the regulation of the immune response
[42–44] including: hematopoietic cell lineage, complement
and coagulation cascades, platelet activation, Toll-like
receptor signaling pathway, NOD-like receptor signaling
pathway, RIG-I-like receptor signaling pathway, cytosolic
DNA-sensing pathway, natural killer cell mediated cytotox-
icity, antigen processing and presentation, T cell receptor
signaling pathway, B cell receptor signaling pathway, Fc ep-
silon RI signaling pathway, Fc gamma R-mediated phago-
cytosis, leukocyte transendothelial migration, intestinal
immune network for IgA production and chemokine
signaling pathway.
miR-451 was the most represented miRNA in spleen
of the virulent infected animals and is also DE between
3 and 7 dpi. Thus, miR-451 is down-regulated at 3 dpi
and up-regulated at 7 dpi. Interestingly, miR-451, was
also DE at 3 dpi in spleen of E75CV1-infected pigs, on
this occasion, showing a clear up-regulation. A similar
expression profile has been described for some key me-
diators of the innate immune response [10], albeit the
target prediction analysis showed that this miRNA was
potentially able to interact with 37 genes, no significant
pathways related to immune response or pathways in-
volved in ASFV-host interaction have been identified.
miR-145-5p was up-regulated at 7 dpi in the spleen
and SLN of the animal infected with the virulent strain.
As described for miR-451, no pathways related to im-
mune response have been predicted for this miRNA,
among the 293 target genes identified. Nevertheless, one
pathway related to ASFV-cell interaction, regulation of
autophagy through ATG12, has been found. The overex-
pression of miR-145-5p at the time of maximal virus
production (7 dpi) might contribute to an inhibition of
autophagy to facilitate ASFV replication and to avoid
virus clearance, as has been postulated before [45].
Fig. 2 Network of DE miRNAs interactions in animals infected with virulent strain and animals infected with attenuated strain. ASFV genes and
porcine genes at 3 dpi involved in virus- host interactions are represented. Hexagon size is proportional to the miRNAs number of interactions.
Circles indicate cellular genes and ovals indicate viral genes. Colors indicate the main pathway/s in which they are involved or the described
function of the viral genes
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miR-92a was DE at different times in the spleens of
animals infected with the virulent strain E75, with its ex-
pression being up-regulated at 3 dpi. When comparing
the spleens of animals infected with the virulent or at-
tenuated strains at 3 dpi, there was also DE, where the
expression is up-regulated by the virulent strain. Target
prediction showed 1192 regulated genes and the path-
way analysis revealed that it was involved in five path-
ways related to immune response, B and T cell receptor
signaling pathways, Fc gamma R-mediated phagocytosis,
chemokine signaling pathway and leukocyte transendothe-
lial migration. Other associated pathways are endocytosis
and regulation of actin cytoskeleton. The participation of
actin in the endocytosis process has been proposed as
stimulator for the entry of large viruses, like vesicular
stomatitis virus [46] and also for ASFV [47], therefore, we
anticipate that miR-92a could be involved in the entry
process of ASFV, corresponding with the peak of virus
replication at 7 dpi.
Another miRNA showing a different expression pat-
tern in spleen between 3 dpi and 7 dpi was miR-23a.
This miRNA was down-regulated at 7 dpi. A large num-
ber of significant pathways were found associated with
miR-23a target genes, some of them related to the im-
mune response, such as RIG-I-like receptor signaling
pathway leukocyte transendothelial migration, Fc gamma
R-mediated phagocytosis, NOD-like receptor signaling
pathway, chemokine signaling pathway, T cell receptor
signaling pathway, hematopoietic cell lineage and Fc ep-
silon RI signaling pathway. On the other hand, pathways
related to the entry of the virus, like endocytosis and
regulation of actin cytoskeleton, as well as other related
to the apoptotic machinery were found. Among the tar-
get genes predicted, Bcl2 and Caspase 3 were two of the
most significant genes involved in apoptosis [48]. Also,
this miRNA regulates eIF2a which is involved in ER
stress processes [49]. Thereby, miR-23a can play a role
in the apoptosis induced by ASFV and in the immune
response against the virus. Compared with 3 dpi, miR-
126-3p was down-regulated in SLN at 7 d after infection
with the virulent E75 strain. Only 20 genes were identi-
fied as possibly regulated by miR-126-3p, and no related
immunological pathways were detected.
miR-126-5p was down-regulated both in SLN and spleen
at 7 dpi after infection with the virulent E75 strain, com-
pared with 3 dpi, and could regulate genes related to the
immune response and many aspects of the virus-host
interaction like entry, apoptosis, regulation of autophagy,
ER stress or chemokine receptors. This regulation could be
in agreement with our observation about miR-126-5p
down-regulation that paralleled the cytokine storm found
during the last stages of ASF acute disease.
Fig. 3 Global miRNA network interaction. Related DE miRNAs in both approaches with cellular target genes involved in ASFV infection and with
viral genes. Hexagon size is proportional to the miRNAs number of interactions. Circles indicate cellular genes and ovals indicate viral genes.
Colors indicate the main pathway/s in which they are involved or the described function of the viral genes
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miR-125b was DE in spleen at 3 dpi between virulent
and attenuated strains, being down-regulated by the
virulent E75 strain. miR-125b was shown to interact with
a large number of genes, thus, some pathways related to
immune response have been identified for this miRNA.
In addition, it has also been associated with pathways in-
volved in the ASFV-cell interaction such as endocytosis,
regulation of actin cytoskeleton and apoptosis [45].
Target prediction analysis showed that miR-125b can
interact with Bcl2. Down-regulation of Bcl2 by miR-
125b might contribute to the inhibition of the early
apoptosis of E75 infected macrophages thus favoring the
success of its replication.
It is worth noting the differential regulation of miR-
30e-5p and miR-125a, two miRNAs that follow opposite
expression profiles that interestingly were conserved for
both tissues studied. Thus, the expression of miR-30e-5p
was up-regulated in SLN and spleen at 3 dpi infected
with the virulent E75 strain, compared to the attenuated
E75CV1, while miR-125a was down-regulated, perhaps
playing opposite regulatory roles during the fine equilib-
rium that separate attenuation from virulence. The fact
that all functions associated with miR-125a are shared
by miR-30e-5p, allowed us to hypothesize about the
relevant roles for pathways specifically regulated by over-
expressing miR-30e-5p early after infection with virulent
E75 ASFV strain, and contributing to the inhibition of
key macrophage innate defensive mechanisms such as
mTOR, toll-like receptors, RIG-I-like receptors, cell adhe-
sion molecules, chemokine signaling pathways, Fc gamma
R-mediated phagocytosis, leukocyte transendothelial mi-
gration or CAMs. Down-regulation of any of these path-
ways might contribute to successful evasion of the innate
immune response.
miR-122 was not expressed in spleen at 3 dpi of ani-
mal infected with the virulent E75. Conversely, its ex-
pression was notably high at day 7pi. A small number of
pathways related with immune response have been ob-
served for this miRNA and it has only been associated
with the endocytosis pathway.
Thus, from this analysis we can conclude that ASFV
modifies miRNA expression patterns involved in the im-
mune response and might contribute to the course of
the disease during the infection.
From the gene network analysis, we found that some
miRNAs like miR-451 and miR-145-5p, which are the most
represented DE miRNAs in spleen, and are highly up-
regulated at 7 dpi, are associated with the viral gene
1242 L. This gene, also regulated by miR-125a and miR-
125b, is involved in RNA transcription and processing [50].
ASFV genome transcription is carried out without using
the host RNA polymerase II. The described gene function
for this gene is RNA polymerase subunit 2 making it a can-
didate to explore as a target to regulate viral replication.
miR-125a additionally targets the viral gene P1192R,
which codes for a type II DNA topoisomerase that is essen-
tial for viral replication and/or transcriptional events [51].
In addition, this topoisomerase has been proposed as a
potential target to control the disease by using poisons and
inhibitors against this enzyme [52]. Down-regulation of
miR-125a might contribute to evade blockade of P1192R,
thus contributing to the efficient replication of the E75
virulent virus.
Interestingly, the three miRNAs that interact with Bcl2
(miR-23a, miR-125a and miR-125b), do not theoretically
regulate A179L, the homologous viral gene of the apop-
tosis inhibitor gene Bcl2 [53]. In spite of the high degree
of structural similarity to all Bcl-2 proteins [54], the se-
quence divergence between both genes might explain
this differential regulation and might contribute to the
successful apoptosis inhibition of the infected macro-
phage until the virus cycle is finished.
miR-92a interacts with the three genes identified as
being involved in ASFV entry, EEA1, EGFR and PIK-
FYVE [55, 56] both in the virulent infection at 3 and 7
dpi and between attenuated and virulent at 3 dpi. Inter-
estingly, this miRNA was found in much higher levels
(thirteen times) in spleen of the animal inoculated with
the virulent strain at 3 dpi compared to spleens of ani-
mals inoculated with the attenuated strain. This differ-
ence of expression could be involved in the differences
in the dynamics of virus infection depending on its viru-
lence and, is in accordance with the recent study where
the diminution of PIKFYVE decreased the ASFV infect-
ivity and viral production [57].
Target prediction for miR-122 revealed that it interacts
with 12 different viral genes classified in multigene
family, replication, genes with unknown function and
unknown genes. This miRNA interacts with MGF 360-
16R and it has recently been described that this viral
multigene family component modulates host innate
responses by determining the tropism, virulence and
suppression of type I IFN response [57]. In addition,
miR-122, together with miR-126-5p, target ATG6, which
is activated by ASFV. The virus uses the ER as a site of
replication and this process of activation of ATF6 can
trigger ER stress and the unfolded protein response (UPR)
of the host cell [58]. miR-122 is the DE miRNA with the
highest number of viral target genes and none of these is
regulated by other miRNAs. On the other hand, miR-122
is not express in spleen from an infected animal with the
virulent E75 strain at 3 dpi, while at 7 dpi its expression
was notably increased. In addition, it is well known that
miR-122 plays a key role in Hepatitis C virus infection
[59]. Accordingly, this miRNA could be involved in the
regulation of the “success of the ASFV infection”.
To our knowledge, this is the first time that a deep se-
quencing approach has been used to study miRNA gene
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expression in pigs infected with ASFV. However, a larger
number of animals as well as functional analysis would
be necessary to support the results obtained in this
study. These investigations could confer a more accurate
vision of the relation between miRNAs with porcine tar-
get genes and ASFV genes to help decipher the role of
miRNAs in ASFV infection.
Conclusion
In this proof-of-concept study, we have been able to
identify differentially expressed porcine miRNAs during
ASFV infection. These DE miRNAs have been observed
at different times post ASFV infection and between dif-
ferent strains with differences in virulence. From these
miRNAs, their host and viral target genes and the path-
ways related to the disease in which they are involved
have been analyzed. Therefore, this information will con-
tribute to our knowledge on ASFV infections and help
clarify host- pathogen interactions, the mechanisms of
the viral infection and the development of the disease.
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